Literature DB >> 7103442

Antibiotic entry into human polymorphonuclear leukocytes.

R C Prokesch, W L Hand.   

Abstract

Since bacteria which survive within phagocytes may produce serious infection, antibiotics which inactivate these intracellular organisms are needed. To establish those factors which mediate entry of antimicrobial agents into human phagocytes, we studied the uptake of 13 radiolabeled antibiotics by peripheral blood polymorphonuclear leukocytes (PMN). At intervals during a 2-h incubation period, antibiotic uptake by PMN was determined by means of velocity gradient centrifugation, which separates the cell-associated antibiotic from the extracellular antibiotic. Penicillin G and three cephalosporin antibiotics penetrated PMN poorly. The ratio of cellular concentration to extracellular concentration (C/E) of these drugs was less than 0.01 to 0.5. For gentamicin and isoniazid, the C/E values were approximately 0.8 to 1.0. Chloramphenicol, rifampin, and lincomycin, antibiotics with good lipid solubility, were concentrated twofold (C/E = 2) in PMN. Ethambutol (C/E = 5), clindamycin (C/E = 11), and two erythromycin preparations (C/E = 10 to 13) were markedly concentrated within PMN. Clindamycin uptake was rapid: greater than 70% of the total drug entry occurred within the first minute. Accumulation of clindamycin and erythromycin was an active, energy-requiring process, dependent at least in part upon glycolysis. Clindamycin entered PMN by means of an active membrane transport system which was saturable and had a high binding affinity (Km = 2 mM) and maximum velocity of uptake (Vmax = 5 nmol/45 s per 10(6) cells). These observations, together with studies of the biological consequences of intracellular antibiotics, should lead to more effective therapy for infection due to intracellular pathogens..

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103442      PMCID: PMC181898          DOI: 10.1128/AAC.21.3.373

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  The pulmonary-alveolar macrophage (first of two parts).

Authors:  W G Hocking; D W Golde
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

2.  The effect of antibiotics on Escherichia coli ingested by macrophages.

Authors:  M C Lobo; G L Mandell
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

3.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

4.  Effect of antibiotics on the bactericidal activity of human leukocytes.

Authors:  J W Alexander; R A Good
Journal:  J Lab Clin Med       Date:  1968-06

5.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

6.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

7.  Protection of phagocytized bacteria from the killing action of antibiotics.

Authors:  B Holmes; P G Quie; D B Windhorst; B Pollara; R A Good
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

8.  Interaction of intraleukocytic bacteria and antibiotics.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

  8 in total
  93 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils.

Authors:  G L Mandell; E Coleman
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Activities of antimicrobial agents against intracellular pneumococci.

Authors:  G L Mandell; E J Coleman
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Antibacterial and immunostimulatory properties of chemotactic N-formyl peptide conjugates of ampicillin and amoxicillin.

Authors:  B W Bycroft; P M Lockey; A Penrose; R J Grout; P Williams
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.

Authors:  Prakash M Jeena; William R Bishai; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

6.  In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.

Authors:  M O Frank; G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 7.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

8.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections.

Authors:  J E Foweraker; N J Cooke; P M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.